doi: 10.3389/fphar.2025.1562896 Received 23 January 2025 Accepted 05 May 2025 Published 02 June 2025 Corrected 09 June 2025 Volume 16 - 2025 Edited by Ahmed Ghallab, Leibniz Research Centre for Working Environment and Human Factors (IfADo), Germany Reviewed by Madlen Matz-Soja, Leipzig University, Germany Mohamed Albadry, University Hospital Jena, Germany Updates Copyright 2025 Sun, Shang, Lv, Liu, Wu and Geng
Standard oral formulations achieve only 0.7% bioavailability, limiting blood level increases compared to IV delivery
Several small studies and case reports suggest that patients with psoriasis may experience improvement after initiating GLP-1 receptor agonists
Plaintiffs argue that the manufacturer of Ozempic, Novo Nordisk, failed to warn consumers about potential harm when taking the injection
Liraglutide, marketed under names like Victoza and Saxenda, typically requires daily injections and is approved at different dosages for diabetes and weight management
10.1007/s00125-024-06198-1 15 Camunas-SolerJ.DaiX.-Q.HangY.BautistaA.LyonJ.SuzukiK.et al (2020)